22 min listen
The journey of clinical trials - an interview with Matt Barthel
Fromunder CTRL
ratings:
Length:
50 minutes
Released:
Oct 18, 2020
Format:
Podcast episode
Description
How do Pharma companies handle ultra sensitive data whilst some of the largest companies are racing to develop COVID-19 vaccination? CTO and Data Protection Officer of Adamas Consulting Group, Matt Barthel sheds some light on this complex matter. We discuss clinical trials, data security and compliance within this highly regulated industry and touch on the privacy challenges COVID-19 has brought upon healthcare.You can find todays guest on https://www.linkedin.com/in/matt-barthel-dip-rqa-mrqa-ispe-iapp-53991515/ and learn more about Adamas Consulting Group on https://www.adamasconsulting.com. And if you want to know what we are up to you can follow us on twitter @tresorit and LinkedIn @linkedin.com/company/tresorit/ and learn more about our company on www.tresorit.com
Released:
Oct 18, 2020
Format:
Podcast episode
Titles in the series (48)
Schrems II: The invalidated Privacy Shield and its aftermath – a walkthrough with Jitty van Doodewaerd: With the Schrems 2 ruling finalized in July, how will enterprise data protection be affected? What is the future of the EU-US Privacy Shield? We chat with Jitty van Doodewaerd from DMCC who was formerly part of the Big Data Expert Group of the Dutch Ministry of Economic Affairs. You can find todays guest on https://www.linkedin.com/in/jitty-van-doodewaerd-0424816/ and learn more about DMCC Netherlands on https://dmcc.nl/. And if you want to know what we are up to you can follow us on twitter @tresorit and LinkedIn @linkedin.com/company/tresorit/ and learn more about our company on www.tresorit.com by under CTRL